$0.96
9.63% today
Nasdaq, Dec 30, 10:15 pm CET
ISIN
US29970R1059
Symbol
EVAX
Sector
Industry

Evaxion Biotech A/S - ADR Target price 2024 - Analyst rating & recommendation

Evaxion Biotech A/S - ADR Classifications & Recommendation:

Buy
100%

Evaxion Biotech A/S - ADR Price Target

Target Price $9.42
Price $0.96
Potential
Number of Estimates 3
3 Analysts have issued a price target Evaxion Biotech A/S - ADR 2025 . The average Evaxion Biotech A/S - ADR target price is $9.42. This is higher than the current stock price. The highest price target is
$14.00 1,361.53%
register free of charge
, the lowest is .
A rating was issued by 2 analysts: 2 Analysts recommend Evaxion Biotech A/S - ADR to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Evaxion Biotech A/S - ADR stock has an average upside potential 2025 of . Most analysts recommend the Evaxion Biotech A/S - ADR stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 0.07 4.48
6,300.43%

3 Analysts have issued a sales forecast Evaxion Biotech A/S - ADR 2024 . The average Evaxion Biotech A/S - ADR sales estimate is

$4.5m
Unlock
. This is
35.77% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.5m 98.21%
Unlock
, the lowest is
$3.2m 3.03%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $70.0k
2024
$4.5m 6,300.43%
Unlock
2025
$7.9m 76.89%
Unlock
2026
$26.6m 235.02%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
EV/Sales 1.84

Based on analysts' sales estimates for 2024, the Evaxion Biotech A/S - ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 29.43
2024
1.84 93.75%
Unlock
2025
1.04 43.47%
Unlock
2026
0.31 70.15%
Unlock

P/S ratio

Current
2024
1.28 26.34%
Unlock
2025
0.72 43.47%
Unlock
2026
0.22 70.15%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today